 BRM
technicians have tested the efficacy of compounds in
the following models:
- Diabetic models
- BBDP/Wor rats
- BBDR/Wor rats
- BBZDR/Wor rats
- NOD mice
- Db/db mice
- Streptozotocin-induced diabetes
- Obese animals
- BBZDR/Wor rats
- Diet-induced mice and rats
- Ob/Ob mice
- ZDF rats
- Inflammatory
models
- Carrageenan-induced paw edema in the rat
- Croton oil-induced ear edema in the rat
- Rheumatoid arthritis
- Collagen-induced in the rat
- Transgenic mouse models
- TNBS-induced irritable bowel syndrome in
the rat
- Experimental autoimmune encephalitis in
the mouse
- Hypophysectomized rats
- Mouse models of autosomal polycystic
kidney disease
- Haloperidol-induced catalepsy
- Vascular leak syndrome in SCID
mice
- Rat wound healing models
|
BRM performs a wide range of
non-clinical laboratory studies that support new
drug applications (NDAs) for permits regulated by
the Food and Drug Administration (FDA).
Custom assays to evaluate the efficacy
of your compound can be designed and implemented by
trained BRM staff.
We can evaluate the effectiveness of
your compound using our proprietary research models
or other commercially available models.
Learn more about:
Efficacy
Toxicology
Pharmacokinetics (PK)
Contact
us for custom research design.
|
